Effects of chemotherapy during pregnancy on the placenta

Pediatric and Developmental Pathology

Volumn 12, Issue 1, 2009, Pages 35-41

  Abellar, Rosanna G ^a,b   Pepperell, John R ^a,b   Greco, David ^a   Gundogan, Fusun ^a,b   Kostadinov, Stefan ^a,b   Schwartz, Joanna ^a   Tantravahi, Umadevi ^a,b   De Paepe, Monique E ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cancer; Doxorubicine; Imatinib; Malignancy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; FLUOROURACIL; IMATINIB; IRINOTECAN; NAVELBINE; OXALIPLATIN; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CLEFT PALATE; CLINICAL ARTICLE; CONGENITAL MALFORMATION; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPOLYPLOIDY; INTRAUTERINE GROWTH RETARDATION; LEUKEMIA; LYMPHOMA; NEOPLASM; OVARY CARCINOMA; PLACENTA; PLACENTA DISORDER; POLYPLOIDY; PREGNANCY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SALIVARY GLAND CARCINOMA; SIDE EFFECT; TRACHEOESOPHAGEAL FISTULA; TROPHOBLAST; UTERINE CERVIX CARCINOMA;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT, NEWBORN; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES;

EID: 61449181312     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-03-0435.1     Document Type: Article

References (25)

1. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283-291.
2. Donegan WL. Cancer and pregnancy. CA Cancer J Clin 1983;33:194-214.
3. Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 2002;7:279-287.
4. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 2005;23:4192-4197.
5. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337-346.
6. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992;152:573-576.
7. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy Pharmacol Ther 1997;74:207-220.
8. Kerr JR. Neonatal effects ofbreast cancer chemotherapy administered during pregnancy. Pharmacotherapy 2005;25:438-441.
9. Gwyn K. Children exposed to chemotherapy in utero. J Natl Cancer Inst Monogr 2005;34:69-71.
10. Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995;28:235-269.
11. Karp GI, von Oeyen P, Valone F, et al. Doxorubicin in pregnancy:possible transplacental passage. Cancer Treat Rep 1983;67:773-777.
12. Beckman DA, Koszalka TR, Jensen M, Brent RL. Experimental manipulation ofthe rodent visceral yolksac. Teratology 1990;41:395-404.
13. Kolonin MG, Pasqualini R, Arap W. Teratogenicity induced by targeting a placental immunoglobulin transporter. Proc Natl Acad Sci USA 2002;99:13055-13060.
14. Barnhart K, Coutifaris C, Esposito M. The pharmacology of methotrexate. Expert Opin Pharmacother 2001;2:409-417.
15. Pinar H, Sung CJ, Oyer CE, Singer DB. Reference values for singleton and twin placental weights. Pediatr Pathol Lab Med 1996;16:901-907.
16. Cheville JC, Greiner T, Robinson RA, Benda JA. Ploidy analysis by flow cytometry and fluorescence in situ hybridization in hydropic placentas and gestational trophoblastic disease. Hum Pathol 1995;26:753-757.
17. Marshall RR, Murphy M, Kirkland DJ, Bentley KS. Fluorescence in situ hybridisation with chromosome-specific centromeric probes: a sensitive method to detect aneuploidy. Mutat Res 1996;372:233-245.
18. Deininger MW, Druker BJ. Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev 2003;55:401-423.
19. Savage DG, Antman KH. Imatinib mesylate-a new oral targeted therapy. N Engl J Med 2002;346:683-693.
20. Kurbacher CM, Kurbacher JA, Cree IA, et al. Chemosensitivity of normal human trophoblasts evaluated by a newly developed ATP-based luminescence assay. Anticancer Drugs 2002;13:701-708.
21. Matalon ST, Ornoy A, Fishman A, Drucker L, Lishner M. The effect of 6-mercaptopurine on early human placental explants. Hum Reprod 2005;20:1390-1397.
22. Pye SM, Cortes J, Ault P, et al. The effects of imatinib on pregnancy outcome. Blood 2008;111:5505-5508.
23. Zybina TG, Zybina EV. Cell reproduction and genome multiplication in the proliferative and invasive trophoblast cell populations of mammalian placenta. Cell Biol Int 2005;29:1071-1083.
24. Zybina TG, Frank HG, Biesterfeld S, Kaufmann P. Genome multiplication of extravillous trophoblast cells in human placenta in the course of differentiation and invasion into endometrium and myometrium. II. Mechanisms of polyploidization. Tsitologiia 2004;46:640-648.
25. Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-861.